| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0ae0d4e4b5a64a9a532bffd8513ed029 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-6432
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y304-21006
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y304-21005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y304-21069
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-6464
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-6429
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K19-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-64 |
| filingDate |
2009-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2017-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce1927c04139542ad406a242c9c584f0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_825c01f73fac9475d1c2e6a94e883204
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_062427ec92551c8fbdaeb4abf93eb49b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd7378539a689df80fe34e8493fb50c1 |
| publicationDate |
2017-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2629099-T3 |
| titleOfInvention |
Serine protease derivatives and uses in the prevention or treatment of and blood clotting disorders |
| abstract |
A thrombin-cleavable factor X chimeric derivative in which the native factor X-activating peptide is replaced by a fusion protein comprising a first polypeptide comprising the amino acid sequence ranging from positions 33 to 52 of SEQ ID NO: 2, wherein the asparagine at position 39 and / or 49 is N-glycosylated, and a second polypeptide comprising the amino acid sequence from positions 7 to 16 of SEQ ID NO: 4 or a thrombin-cleavable factor X-chimeric derivative containing activated factor X or a function-conservative variant thereof and a fusion protein comprising a first polypeptide comprising the amino acid sequence ranging from positions 33 to 52 of SEQ ID NO: 2 wherein the asparagine at position 39 or 49 is N-glycosylated and a second polypeptide comprising the amino acid sequence ranging from positions 7 to 16 of SEQ ID NO: 4. |
| priorityDate |
2008-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |